Jennifer Mandal

Goodwin

Contact
View Bio
RSS

Latest Posts › Life Sciences

Share:

FDA to Review Vertex Pharmaceutical’s Application for CRISPR-based Gene Therapy Exa-cel

The Cellular, Tissue, and Gene Therapies Advisory Committee of the FDA is meeting tomorrow, Tuesday, October 31, 2023, to review a Biologics License Application by Vertex Pharmaceuticals Inc. for exagamglogene autotemcel...more

10/31/2023  /  Food and Drug Administration (FDA) , Life Sciences , Pharmaceutical Industry , Popular , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide